Pallawi Torka, MD

Pallawi Torka, MD, discusses the BTK inhibitors available for treatment of patients with relapsed/refractory mantle cell lymphoma.

Pallawi Torka, MD, discusses the clinical implications of the FDA approval of pirtobrutinib in patients with relapsed or refractory mantle cell lymphoma.

Pallawi Torka, MD, reflects on the lessons learned from an attending physician who inspired his fellows in both life and death.